SG11202003229RA - Methods and compositions for topical delivery - Google Patents

Methods and compositions for topical delivery

Info

Publication number
SG11202003229RA
SG11202003229RA SG11202003229RA SG11202003229RA SG11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA SG 11202003229R A SG11202003229R A SG 11202003229RA
Authority
SG
Singapore
Prior art keywords
compositions
methods
topical delivery
topical
delivery
Prior art date
Application number
SG11202003229RA
Other languages
English (en)
Inventor
Jacob M Waugh
Michael D Dake
Original Assignee
Illustris Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illustris Pharmaceuticals Inc filed Critical Illustris Pharmaceuticals Inc
Publication of SG11202003229RA publication Critical patent/SG11202003229RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11202003229RA 2017-10-11 2018-10-11 Methods and compositions for topical delivery SG11202003229RA (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201762571038P 2017-10-11 2017-10-11
US201762571025P 2017-10-11 2017-10-11
US201762571049P 2017-10-11 2017-10-11
US201762598828P 2017-12-14 2017-12-14
US201762598786P 2017-12-14 2017-12-14
US201762598796P 2017-12-14 2017-12-14
PCT/US2018/055499 WO2019075263A2 (fr) 2017-10-11 2018-10-11 Procédés et compositions à administration topique

Publications (1)

Publication Number Publication Date
SG11202003229RA true SG11202003229RA (en) 2020-05-28

Family

ID=65992336

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003229RA SG11202003229RA (en) 2017-10-11 2018-10-11 Methods and compositions for topical delivery

Country Status (7)

Country Link
US (1) US20190105261A1 (fr)
EP (1) EP3694489A4 (fr)
CN (1) CN111683653A (fr)
CA (1) CA3078631A1 (fr)
IL (1) IL273823A (fr)
SG (1) SG11202003229RA (fr)
WO (1) WO2019075263A2 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG160357A1 (en) * 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
EP3804731A4 (fr) * 2018-06-08 2022-04-06 Sumitomo Seika Chemicals Co., Ltd. Composition pour le traitement de plaies cutanées
EP3823589A1 (fr) * 2018-07-18 2021-05-26 Hillstream Biopharma Inc. Nanoparticules polymères comprenant de la salinomycine
CN112739337B (zh) 2018-07-27 2024-05-24 强生外科视力公司 用于治疗眼睛的组合物和方法
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US20210388070A1 (en) * 2018-10-30 2021-12-16 Alexion Pharmaceuticals, Inc. Co-administration of a hyaluronidase and anti-c5 antibody for treatment of complement-associated conditions
CN110151592B (zh) * 2019-05-09 2022-04-22 杭州科腾生物制品有限公司 一种组合物及其制备方法和用途
CN112007025B (zh) * 2019-05-30 2022-04-19 义慧科技(深圳)有限公司 米拉贝隆在制备预防和/或治疗恶性肿瘤的药物中的应用
WO2020247874A2 (fr) * 2019-06-07 2020-12-10 Diomics Corporation Administration topique à action retard faisant appel à un biopolymère en couches
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
CN110327285A (zh) * 2019-07-15 2019-10-15 张正华 他汀类药膏的制备方法及其在治疗汗孔角化症中的应用
FR3101544B1 (fr) * 2019-10-07 2023-09-29 Sederma Sa Traitement cosmétique ou dermatologique a base de peptide(s) de la peau et de ses phanères
CN110731943B (zh) * 2019-10-15 2022-02-08 河南牧翔动物药业有限公司 一种氢溴酸常山酮可溶性粉及其制备方法
WO2021076875A1 (fr) * 2019-10-18 2021-04-22 University Of Maryland Nouveau principe actif dans des compositions de produits de protection solaire
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
KR102201133B1 (ko) * 2020-01-31 2021-01-11 진로사 피부 노화 방지 및 국소 지방 분해용 조성물
CN111249298B (zh) * 2020-04-08 2021-03-12 曲阜师范大学 一种含有马杜霉素和顺铂的抗癌药物组合物
EP4019058A4 (fr) * 2020-05-14 2022-12-14 Nantong University Microsphère de plga modifiée par des protéines et nerf obtenu par génie tissulaire ainsi construit
CN115734784A (zh) * 2020-05-21 2023-03-03 平衡治療有限責任公司 用于控制甲状腺激素水平的微针装置
KR20240127867A (ko) * 2020-08-10 2024-08-23 지로파, 인코포레이티드 국소 전달을 위한 조성물 및 방법
US20220054412A1 (en) * 2020-08-20 2022-02-24 Jason Pool Topical formulation and methods for neuropathy relief
CN112316158B (zh) * 2020-11-19 2021-09-21 四川大学 一种利用超分子包合剂关闭胶原溶液中抗菌剂活性的方法
CN112630207B (zh) * 2020-12-24 2021-12-28 江南大学 一种猪肉中齐帕特罗残留的快速检测方法
WO2022150657A1 (fr) * 2021-01-07 2022-07-14 AB BioInnovations, Inc. Compositions de colorant thiazine thérapeutiques et méthodes d'utilisation
CN113018504A (zh) * 2021-03-11 2021-06-25 华沃生物科技(武汉)有限公司 一种抗过敏鼻部液体敷料及其制备方法
CN112972379B (zh) * 2021-03-17 2023-04-25 项朝荣 一种加米霉素乳剂及制备方法与在防治猪回肠炎方面的应用
JP2024522066A (ja) * 2021-05-17 2024-06-11 ザ キュレイターズ オブ ザ ユニバーシティ オブ ミズーリ 金、銀及び豊富なファイトケミカルペイロードナノ材料、抗ウイルス／抗菌製品、並びに合成方法
CN113304309A (zh) * 2021-06-02 2021-08-27 青岛大学 用于伤口皮肤修复的复方水凝胶贴片及其制备方法
KR102350612B1 (ko) * 2021-06-09 2022-01-11 어유정 여성 젖몸살 완화 효과가 있는 화장료 조성물
CN115671267A (zh) * 2021-07-23 2023-02-03 上海宝济药业有限公司 一种皮下抗生素药物组合物
CN113588626B (zh) * 2021-08-24 2024-05-24 上海师范大学 一种苯丙氨酸对映体的拉曼光谱检测方法
CN113621445A (zh) * 2021-09-09 2021-11-09 泸州市振泽科技有限责任公司 一种农作物秸秆表面腊质湿润和破坏制剂及使用方法
US20230111190A1 (en) * 2021-09-14 2023-04-13 Nulixir Inc. Oral compositions with improved bioavailability and methods of making the same
CN113813230B (zh) * 2021-10-18 2023-03-14 佛山市南海东方澳龙制药有限公司 一种加米霉素注射用微乳及其制备方法
CN115990240A (zh) * 2021-10-20 2023-04-21 富比积生物科技股份有限公司 寡肽在治疗牙龈发炎、牙龈萎缩及修复口腔黏膜中的用途
CN114015126B (zh) * 2021-10-28 2022-08-30 南开大学 一种食品包装膜材料制备及应用
WO2023119230A1 (fr) 2021-12-22 2023-06-29 L'oreal Compositions de modulation de la voie de coagulation et de la voie de nicotinamide-adénine dinucléotide et leurs procédés d'utilisation
WO2023130064A2 (fr) * 2021-12-30 2023-07-06 Sincerus Pharmaceuticals, Inc. Formule anti-âge améliorée
WO2023131872A2 (fr) * 2022-01-04 2023-07-13 Bartov Noa Techniques d'administration rectale
EP4460310A1 (fr) * 2022-01-05 2024-11-13 Asymmetric Therapeutics, Llc Méthodes et compositions pour le traitement de troubles cutanés prolifératifs et d'autres affections cutanées
CN114377122B (zh) * 2022-01-18 2023-04-07 四川大学 一种基于四面体框架核酸的复合佐剂、mRNA疫苗及其制备方法和用途
CN114414809B (zh) * 2022-03-28 2022-06-21 中元伯瑞生物科技(珠海横琴)有限公司 用于诊断尘肺病的生物标志物的应用
CN117186177B (zh) * 2022-05-31 2024-08-23 中国农业大学 一种具有降尿酸活性的鸭血球蛋白肽及其制备方法
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
CN115137667B (zh) * 2022-08-11 2024-09-20 深圳市宗匠科技有限公司 一种具有促渗功效的化妆品组合物及其应用
CN115381771A (zh) * 2022-08-30 2022-11-25 四川博大金点生物技术有限公司 一种泰乐菌素注射液及其制备方法
WO2024050145A1 (fr) * 2022-09-02 2024-03-07 Rs Oncology, Llc Schémas posologiques de thiostrepton
CN115770756B (zh) * 2022-12-01 2024-09-27 九信(武汉)中药研究院有限公司 降低决明子灰分的方法
WO2024130106A1 (fr) * 2022-12-16 2024-06-20 The Texas A&M University System Nanoparticules de carbone oxydées pour le traitement d'affections cutanées oxydatives
WO2024137819A1 (fr) * 2022-12-23 2024-06-27 Annadurai Dharmarajan Composition topique de récupération musculaire lors d'un entraînement et son procédé d'application
WO2024191498A1 (fr) * 2023-03-13 2024-09-19 Board Of Trustees Of The University Of Arkansas Compositions larvicides microencapsulées par levure et leurs procédés de fabrication et d'utilisation
CN116496492B (zh) * 2023-04-04 2024-09-06 兰州大学 植酸和多肽双重修饰的聚酰胺-胺型树枝状聚合物及其制备方法和应用
CN116392505A (zh) * 2023-04-10 2023-07-07 上海市东方医院（同济大学附属东方医院） 钼纳米粒子在制备用于治疗生发的药物中的用途
CN117180302B (zh) * 2023-11-06 2024-01-12 山东中医药大学第二附属医院(山东省中西医结合医院) 一种多糖在口腔粘膜修复中的应用及其所制备的促进剂
CN117427027B (zh) * 2023-12-21 2024-04-23 舒芙雅生物科技有限公司 一种祛痘组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713747D0 (en) * 1987-06-12 1987-07-15 Unilever Plc Skin treatment composition
IT1260148B (it) * 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
US8916539B2 (en) * 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
MXPA03011987A (es) * 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
DK1968648T3 (en) * 2005-12-16 2015-07-27 Amit Shachaf Diagnostic system for the detection and diagnosis of skin cancer
US9532943B2 (en) * 2010-12-20 2017-01-03 Cormatrix Cardiovascular, Inc. Drug eluting patch for the treatment of localized tissue disease or defect
EP2268306A2 (fr) * 2008-03-14 2011-01-05 The Board Of Trustees Of The University Of Illinois Antigènes thérapeutiques contre le cancer
JP5916388B2 (ja) * 2008-11-14 2016-05-11 ヒストジェン インコーポレイテッド がんの処置のための細胞外マトリックス組成物
JP2013521300A (ja) * 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
CH705713B1 (de) * 2012-09-21 2013-05-15 Labo Cosprophar Ag Dermokosmetische Zusammensetzung zur topischen Anwendung.
US20160000834A1 (en) * 2013-02-28 2016-01-07 Ventrix, Inc. Methods and compositions for tissue therapy and analysis
RU2714404C2 (ru) * 2014-01-31 2020-02-14 Фэктор Байосайенс Инк. Способы и продукты для получения и доставки нуклеиновых кислот
AU2017250267A1 (en) * 2016-04-12 2018-11-08 Illustris Pharmaceuticals, Inc. Compositions for topical application of compounds

Also Published As

Publication number Publication date
AU2018347514B2 (en) 2024-08-01
US20190105261A1 (en) 2019-04-11
WO2019075263A2 (fr) 2019-04-18
EP3694489A2 (fr) 2020-08-19
WO2019075263A3 (fr) 2020-03-26
CN111683653A (zh) 2020-09-18
AU2018347514A1 (en) 2020-05-07
EP3694489A4 (fr) 2021-06-30
IL273823A (en) 2020-05-31
CA3078631A1 (fr) 2019-04-18

Similar Documents

Publication Publication Date Title
IL273823A (en) Methods and preparations for local administration
HK1258900A1 (zh) 遞送方法和組合物
IL282304A (en) Pharmaceutical preparations for local use
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
EP3379935A4 (fr) Procédés et compositions pour réduire une infection ou colonisation d'enterococci
IL268684A (en) Preparations and methods for immuno-oncology
ZA201606704B (en) Topical corticosteroid compositions
GB201807325D0 (en) Compositions and methods
IL274524A (en) Preparations and methods for aquaculture
SG11202000615VA (en) Topical composition
IL265831A (en) Preparations and methods for protein expression and administration
IL268583A (en) Preparations and methods for use on the skin
EP3223793A4 (fr) Compositions et procédés d'administration d'un agent bio-actif ou d'agents bio-actifs
ZA202004533B (en) Skin-brightening compositions and methods
PT3373976T (pt) Formulações tópicas e suas utilizações
IL268374A (en) Topical compounds
IL272945A (en) Local preparations and methods of treatment
IL272944A (en) local preparations
GB201713160D0 (en) Topical composition
EP3322482C0 (fr) Compositions topiques de ciprofloxacine
PL3072529T3 (pl) Kompozycja zawierająca wemurafenib i HPMC-AS
GB2564026B (en) Topical composition and delivery system and its use
GB201701970D0 (en) Topical composition
GB201704298D0 (en) Compositions and methods
AU2015900007A0 (en) Anti-microbial methods and compositions